MiR-145 Regulates the Proliferation and Apoptosis of Y79 Human Retinoblastoma Cells by Targeting IGF-1R

Overview

Journal Int J Clin Exp Pathol

Specialty Pathology

Date 2020 Jan 18

PMID 31949829

Citations 4

Authors

Zhen Chen

Hongxia Yang

Yuhong Nie

Yiqiao Xing

Affiliations

Soon will be listed here.

Abstract

Purpose: To investigate the effect of miR-145 on the proliferation and apoptosis of human retinoblastoma Y79 cells and to explore the underlying mechanism.

Method: The Y79 cells were transfected by miR-145 mimics and IGF-1R siRNA with lipofection, respectively. The expression of miR-145 or IGF-1R was detected after transfection by real time-PCR. Cell proliferation inhibition was measured by Cell Counting Kit-8 (CCK-8) assay. Flow cytometry was used to examine cell cycles. Apoptosis was detected by Annexin/PI double immunofluorescence and flow cytometer. The interaction between miR-145 and IGF-1R was tested by luciferase activity measurement.

Results: The expression of miR-145 in the miR-145 mimics group was significantly increased (<0.05). The proliferation inhibition rate was higher in the miR-145 mimics group (<0.01). The results of immunofluorescence and flow cytometry showed that ratios of Annexin or Annexin/PI double positive were increased in the miR-145 mimics group (<0.05). The OD value of proliferation inhibition was lower in the IGF-1R siRNA group (<0.05). The ratios of Annexin or Annexin/PI double positive were higher in the IGF-1R siRNA group (<0.05). Luciferase activity was reduced in miR-145 mimics group (<0.01).

Conclusion: miR-145 inhibited proliferation and induced apoptosis in Y79 cells. Lower expression of IGF-1R suppressed the proliferation of Y79 cells. miR-145 restrained the proliferation of human retinoblastoma Y79 cells by down-regulating the expression of IGF-1R.

Citing Articles

The role of MicroRNAs in mesenchymal stem cell differentiation into vascular smooth muscle cells.

Abolhasani S, Ahmadi Y, Rostami Y, Fattahi D Cell Div. 2025; 20(1):6.

PMID: 40055797 PMC: 11887104. DOI: 10.1186/s13008-025-00146-0.

MicroRNA‑153‑3p suppresses retinoblastoma cell growth and invasion via targeting the IGF1R/Raf/MEK and IGF1R/PI3K/AKT signaling pathways.

Guo L, Bai Y, Ni T, Li Y, Cao R, Ji S Int J Oncol. 2021; 59(1).

PMID: 34036380 PMC: 8143749. DOI: 10.3892/ijo.2021.5227.

The Interplay Between Non-coding RNAs and Insulin-Like Growth Factor Signaling in the Pathogenesis of Neoplasia.

Ghafouri-Fard S, Abak A, Mohaqiq M, Shoorei H, Taheri M Front Cell Dev Biol. 2021; 9:634512.

PMID: 33768092 PMC: 7985092. DOI: 10.3389/fcell.2021.634512.

Liu Z, Huang Y, Zhang F, Tang H, Wang Y Ann Transl Med. 2020; 8(21):1451.

PMID: 33313196 PMC: 7723560. DOI: 10.21037/atm-20-6009.

microRNA-144 functions as a diagnostic and prognostic marker for retinoblastoma.

Zheng Q, Zhu Q, Li C, Hao S, Li J, Yu X Clinics (Sao Paulo). 2020; 75:e1804.

PMID: 32844953 PMC: 7426600. DOI: 10.6061/clinics/2020/e1804.

References

Karatas O, Yuceturk B, Suer I, Yilmaz M, Cansiz H, Solak M . Role of miR-145 in human laryngeal squamous cell carcinoma. Head Neck. 2015; 38(2):260-6. DOI: 10.1002/hed.23890. View

Panza A, Votino C, Gentile A, Valvano M, Colangelo T, Pancione M . Peroxisome proliferator-activated receptor γ-mediated induction of microRNA-145 opposes tumor phenotype in colorectal cancer. Biochim Biophys Acta. 2014; 1843(6):1225-36. DOI: 10.1016/j.bbamcr.2014.03.003. View

Cosaceanu D, Carapancea M, Castro J, Ekedahl J, Kanter L, Lewensohn R . Modulation of response to radiation of human lung cancer cells following insulin-like growth factor 1 receptor inactivation. Cancer Lett. 2005; 222(2):173-81. DOI: 10.1016/j.canlet.2004.10.002. View

Stark A . Determining the incidence of the hereditary form of retinoblastoma. Ann Transl Med. 2016; 4(9):171. PMC: 4876282. DOI: 10.21037/atm.2016.05.05. View

Samani A, Yakar S, LeRoith D, Brodt P . The role of the IGF system in cancer growth and metastasis: overview and recent insights. Endocr Rev. 2006; 28(1):20-47. DOI: 10.1210/er.2006-0001. View

Yap T, Olmos D, Molife L, de Bono J . Targeting the insulin-like growth factor signaling pathway: figitumumab and other novel anticancer strategies. Expert Opin Investig Drugs. 2011; 20(9):1293-304. DOI: 10.1517/13543784.2011.602630. View

Gu S, Kay M . How do miRNAs mediate translational repression?. Silence. 2010; 1(1):11. PMC: 2881910. DOI: 10.1186/1758-907X-1-11. View

Singh P, Alex J, Bast F . Insulin receptor (IR) and insulin-like growth factor receptor 1 (IGF-1R) signaling systems: novel treatment strategies for cancer. Med Oncol. 2013; 31(1):805. DOI: 10.1007/s12032-013-0805-3. View

Samani A, Brodt P . The receptor for the type I insulin-like growth factor and its ligands regulate multiple cellular functions that impact on metastasis. Surg Oncol Clin N Am. 2001; 10(2):289-312, viii. View

10.

van der Veeken J, Oliveira S, Schiffelers R, Storm G, van Bergen En Henegouwen P, Roovers R . Crosstalk between epidermal growth factor receptor- and insulin-like growth factor-1 receptor signaling: implications for cancer therapy. Curr Cancer Drug Targets. 2009; 9(6):748-60. DOI: 10.2174/156800909789271495. View

11.

Sethi S, Kong D, Land S, Dyson G, Sakr W, Sarkar F . Comprehensive molecular oncogenomic profiling and miRNA analysis of prostate cancer. Am J Transl Res. 2013; 5(2):200-11. PMC: 3612515. View

12.

Yang H, Zheng S, Qiu Y, Yang Y, Wang C, Yang P . Activation of liver X receptor alleviates ocular inflammation in experimental autoimmune uveitis. Invest Ophthalmol Vis Sci. 2014; 55(4):2795-804. PMC: 4004425. DOI: 10.1167/iovs.13-13323. View

13.

Matsushita R, Yoshino H, Enokida H, Goto Y, Miyamoto K, Yonemori M . Regulation of UHRF1 by dual-strand tumor-suppressor microRNA-145 (miR-145-5p and miR-145-3p): Inhibition of bladder cancer cell aggressiveness. Oncotarget. 2016; 7(19):28460-87. PMC: 5053739. DOI: 10.18632/oncotarget.8668. View

14.

Varewijck A, Janssen J . Insulin and its analogues and their affinities for the IGF1 receptor. Endocr Relat Cancer. 2012; 19(5):F63-75. DOI: 10.1530/ERC-12-0026. View

15.

Cardillo M, Monti S, Di Silverio F, Gentile V, Sciarra F, Toscano V . Insulin-like growth factor (IGF)-I, IGF-II and IGF type I receptor (IGFR-I) expression in prostatic cancer. Anticancer Res. 2003; 23(5A):3825-35. View

16.

Chen D, Opavsky R, Pacal M, Tanimoto N, Wenzel P, Seeliger M . Rb-mediated neuronal differentiation through cell-cycle-independent regulation of E2f3a. PLoS Biol. 2007; 5(7):e179. PMC: 1914394. DOI: 10.1371/journal.pbio.0050179. View

17.

Caputa G, Schaffer J . RNA Regulation of Lipotoxicity and Metabolic Stress. Diabetes. 2016; 65(7):1816-23. PMC: 4915576. DOI: 10.2337/db16-0147. View

18.

Dimaras H, Corson T, Cobrinik D, White A, Zhao J, Munier F . Retinoblastoma. Nat Rev Dis Primers. 2016; 1:15021. PMC: 5744255. DOI: 10.1038/nrdp.2015.21. View

19.

Prattichizzo F, Giuliani A, De Nigris V, Pujadas G, Ceka A, La Sala L . Extracellular microRNAs and endothelial hyperglycaemic memory: a therapeutic opportunity?. Diabetes Obes Metab. 2016; 18(9):855-67. PMC: 5094499. DOI: 10.1111/dom.12688. View

20.

Kim W, Prudkin L, Feng L, Kim E, Hennessy B, Lee J . Epidermal growth factor receptor and K-Ras mutations and resistance of lung cancer to insulin-like growth factor 1 receptor tyrosine kinase inhibitors. Cancer. 2012; 118(16):3993-4003. PMC: 3674414. DOI: 10.1002/cncr.26656. View